-

Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.

We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit https://investors.hims.com/.

Contacts

Investor Relations
investors@forhims.com

Media Relations
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Versions

Contacts

Investor Relations
investors@forhims.com

Media Relations
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new injectable and oral testosterone replacement therapies (TRT) for eligible men. It’s the largest expansion of the company’s men’s health program since first introducing the category last September, giving eligible men more options to treat low testosterone in partnership with licensed providers through Hims. An estimated 20 million men1,2 i...

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial results after the market closes on Monday, November 9, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and (585) 542-9983 for international participant...

Hers Launches in Australia, Built to Care for the Whole Woman

SYDNEY--(BUSINESS WIRE)--Hims & Hers, the leading global health and wellness platform, today announced the official launch of Hers in Australia, bringing its personalised care platform to women nationwide for the first time. The launch introduces first-of-their-kind treatment programs across Hair, Menopause and Perimenopause, and Weight Loss care - backed by women's-only research and 24/7 Care Team access. The launch marks the rebrand of Juniper, Eucalyptus' women's health platform, which h...
Back to Newsroom